Rongqin Huang Lab, Fudan University

Rongqin Huang Lab

School of Pharmacy, Fudan University

Home

Group Leader

Publications

Recruitment

English 中文

Research interests

Research projects

2019-2021, LRP1-targeted carbon nanodots for crossing BBB and delivering small molecule or protein drugs into brain (Sino-German research project supported by National Natural Science Foundation of China, principal investigator)

2018-2021, Photoacoustic/fluorescent dual-mode imaging-guided glioma-targeted combined therapy based on solid-phase synthesized carbon nanodots (the grant from National Natural Science Foundation of China, principal investigator);

2017-2019, A biosensor for early diagnosis of pancreatic cancer (“Pu Jiang” project supported by Shanghai Government, principal investigator);

2016-2019, Visualized cascade-targeting micelle for combined glioma therapy (the grant from National Natural Science Foundation of China, principal investigator);

2014-2017, Novel peptide-modified precise oligomers for cascade-targeting gene therapy of glioma (Sino-German research project, principal investigator);

2014-2016, Multifunctional nano-scaled systems for synergistic targeted glioma therapy (Cooperation project with Nantong University, principal investigator);

2013-2017, Studies on novel nanodrugs for brain tumors (supported by the grant from National Key Basic Research Program of China (973 Program), participant);

2013-2014, Multi-mode construction of the course “Brain Health and Science (Fudan University, principal investigator);

2012-2014, Glioma-targeting drug delivery (“Zhuo Xue” Talent Plan of Fudan University, principal investigator);

2012-2013, Glioma-targeting drug delivery system based on mesoporous slilica-graphene nanosheets (supported by grant from State Key Laboratory of Molecular Engineering of Polymers of Fudan University, principal investigator);

2011-2013, Cell-penetrating peptide-modified gene delivery system and its anti-tumor studies (“Chen Guang” project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation, principal investigator);

2010-2012, Construction and mechanism studies of T7-modified glioma-targeted double-loaded nano-scaled delivery system (the grant from National Natural Science Foundation of China, principal investigator);

2010-2012, Mechanisms and anti-parkinsonian studies of Angiopep-modified nano-scaled gene delivery system (the grant from Specialized Research Fund for Doctoral Program, principal investigator);

2008-2011, Key technology and product development of nano-drugs targeting to liver cancer (supported by the grant from National High Technology Research and Development Program (863 Program) of China, participant);

2008-2010, Construction and tumor-targeting studies on aptamer-mediated delivery systems (supported by the grant from Shanghai Scientific Research Program, participant).

Email: rqhuang@fudan.edu.cn